← All trials
NCT06569823
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 17, 2024
- Primary completion
- Sep 30, 2026
- Completion date
- Sep 30, 2026
- First posted
- Aug 26, 2024
- Last posted
- Aug 26, 2024
- Enrollment
- 440
- Arms / groups
- 11 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Dynavax Technologies CorporationLead sponsor
- Dynavax Technologies CorporationOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.